798PImpact of the addition of metformin (Met) to abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) progressing on Abi treatment: A phase II pilot study. (18th September 2017)

Record Type:: Journal Article
Title:: 798PImpact of the addition of metformin (Met) to abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) progressing on Abi treatment: A phase II pilot study. (18th September 2017)
Main Title:: 798PImpact of the addition of metformin (Met) to abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) progressing on Abi treatment: A phase II pilot study
Authors:: Mark, M.
Klingbiel, D.
Mey, U.
Winterhalder, R.
Rothermundt, C.
Gillessen, S.
von Moos, R.
Manetsch, G.
Cathomas, R.
Abstract:
Is Part Of:: Annals of oncology. Volume 28(2017)Supplement 5
Journal:: Annals of oncology
Issue:: Volume 28(2017)Supplement 5
Issue Display:: Volume 28, Issue 5 (2017)
Year:: 2017
Volume:: 28
Issue:: 5
Issue Sort Value:: 2017-0028-0005-0000
Page Start:
Page End:
Publication Date:: 2017-09-18
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdx370.015 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12574.xml